Sadia Isfat Ara Rahman1, Zoe A Dyson2,3,4, Elizabeth J Klemm4, Farhana Khanam1, Kathryn E Holt3,5, Emran Kabir Chowdhury6, Gordon Dougan2,4, Firdausi Qadri1. 1. Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh. 2. Department of Medicine, University of Cambridge, Cambridge, United Kingdom. 3. Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, Australia. 4. Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom. 5. Department of Infection Biology, Faculty of Infections and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom. 6. Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh.
Abstract
BACKGROUND: Multi-drug resistant typhoid fever remains an enormous public health threat in low and middle-income countries. However, we still lack a detailed understanding of the epidemiology and genomics of S. Typhi in many regions. Here we have undertaken a detailed genomic analysis of typhoid in urban Dhaka, Bangladesh to unravel the population structure and antimicrobial resistance patterns in S. Typhi isolated between 2004-2016. PRINCIPAL FINDINGS: Whole genome sequencing of 202 S. Typhi isolates obtained from three study locations in urban Dhaka revealed a diverse range of S. Typhi genotypes and AMR profiles. The bacterial population within Dhaka were relatively homogenous with little stratification between different healthcare facilities or age groups. We also observed evidence of exchange of Bangladeshi genotypes with neighboring South Asian countries (India, Pakistan and Nepal) suggesting these are circulating throughout the region. This analysis revealed a decline in H58 (genotype 4.3.1) isolates from 2011 onwards, coinciding with a rise in a diverse range of non-H58 genotypes and a simultaneous rise in isolates with reduced susceptibility to fluoroquinolones, potentially reflecting a change in treatment practices. We identified a novel S. Typhi genotype, subclade 3.3.2 (previously defined only to clade level, 3.3), which formed two localized clusters (3.3.2.Bd1 and 3.3.2.Bd2) associated with different mutations in the Quinolone Resistance Determining Region (QRDR) of gene gyrA. SIGNIFICANCE: Our analysis of S. Typhi isolates from urban Dhaka, Bangladesh isolated over a twelve year period identified a diverse range of AMR profiles and genotypes. The observed increase in non-H58 genotypes associated with reduced fluoroquinolone susceptibility may reflect a change in treatment practice in this region and highlights the importance of continued molecular surveillance to monitor the ongoing evolution of AMR in Dhaka. We have defined new genotypes and lineages of Bangladeshi S. Typhi which will facilitate the identification of these emerging AMR clones in future surveillance efforts.
BACKGROUND: Multi-drug resistant typhoid fever remains an enormous public health threat in low and middle-income countries. However, we still lack a detailed understanding of the epidemiology and genomics of S. Typhi in many regions. Here we have undertaken a detailed genomic analysis of typhoid in urban Dhaka, Bangladesh to unravel the population structure and antimicrobial resistance patterns in S. Typhi isolated between 2004-2016. PRINCIPAL FINDINGS: Whole genome sequencing of 202 S. Typhi isolates obtained from three study locations in urban Dhaka revealed a diverse range of S. Typhi genotypes and AMR profiles. The bacterial population within Dhaka were relatively homogenous with little stratification between different healthcare facilities or age groups. We also observed evidence of exchange of Bangladeshi genotypes with neighboring South Asian countries (India, Pakistan and Nepal) suggesting these are circulating throughout the region. This analysis revealed a decline in H58 (genotype 4.3.1) isolates from 2011 onwards, coinciding with a rise in a diverse range of non-H58 genotypes and a simultaneous rise in isolates with reduced susceptibility to fluoroquinolones, potentially reflecting a change in treatment practices. We identified a novel S. Typhi genotype, subclade 3.3.2 (previously defined only to clade level, 3.3), which formed two localized clusters (3.3.2.Bd1 and 3.3.2.Bd2) associated with different mutations in the Quinolone Resistance Determining Region (QRDR) of gene gyrA. SIGNIFICANCE: Our analysis of S. Typhi isolates from urban Dhaka, Bangladesh isolated over a twelve year period identified a diverse range of AMR profiles and genotypes. The observed increase in non-H58 genotypes associated with reduced fluoroquinolone susceptibility may reflect a change in treatment practice in this region and highlights the importance of continued molecular surveillance to monitor the ongoing evolution of AMR in Dhaka. We have defined new genotypes and lineages of Bangladeshi S. Typhi which will facilitate the identification of these emerging AMR clones in future surveillance efforts.
Authors: Farah N Qamar; Mohammad T Yousafzai; Irum F Dehraj; Sadia Shakoor; Seema Irfan; Aneeta Hotwani; Muhammad J Hunzai; Rozina S Thobani; Najeeb Rahman; Junaid Mehmood; Caitlin Hemlock; Ashraf M Memon; Jason R Andrews; Stephen P Luby; Denise O Garrett; Ashley T Longley; Kashmira Date; Samir K Saha Journal: Clin Infect Dis Date: 2020-12-01 Impact factor: 9.079
Authors: Sadia Isfat Ara Rahman; Alyce Taylor-Brown; Farhana Khanam; Ashraful Islam Khan; Gal Horesh; Zoe A Dyson; Yasmin Ara Begum; Emran Kabir Chowdhury; Firdausi Qadri; Gordon Dougan; Nicholas R Thomson Journal: Microb Genom Date: 2021-09
Authors: Samuel Kariuki; Zoe A Dyson; Cecilia Mbae; Ronald Ngetich; Susan M Kavai; Celestine Wairimu; Stephen Anyona; Naomi Gitau; Robert Sanaya Onsare; Beatrice Ongandi; Sebastian Duchene; Mohamed Ali; John David Clemens; Kathryn E Holt; Gordon Dougan Journal: Elife Date: 2021-09-13 Impact factor: 8.140
Authors: Sadia Isfat Ara Rahman; To Nguyen Thi Nguyen; Farhana Khanam; Nicholas R Thomson; Zoe A Dyson; Alyce Taylor-Brown; Emran Kabir Chowdhury; Gordon Dougan; Stephen Baker; Firdausi Qadri Journal: PLoS Negl Trop Dis Date: 2021-10-14
Authors: Deborah A Williamson; Benjamin P Howden; Danielle J Ingle; Patiyan Andersson; Mary Valcanis; Mathilda Wilmot; Marion Easton; Courtney Lane; Jessica Barden; Anders Gonçalves da Silva; Torsten Seemann; Kristy Horan; Susan A Ballard; Norelle L Sherry Journal: Antimicrob Agents Chemother Date: 2021-09-20 Impact factor: 5.191